Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (181-190 of 218) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|December 8, 2005
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivationJoan S Lewis, Kathleen Meeke, Clodia Osipo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 4, 2004
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2Barry D Gehm, Anait S Levenson, Hong Liu, et al.
Gynecologic Oncology|June 20, 2012
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contaminationChristopher Korch, Monique A Spillman, Twila A Jackson, et al.
The Journal of Biological Chemistry|March 18, 2003
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functionsSandip K Mishra, Abhijit Mazumdar, Ratna K Vadlamudi, et al.
International Journal of Cancer|February 21, 2003
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alphaAnait S Levenson, Barry D Gehm, Sandra Timm Pearce, et al.
British Journal of Pharmacology|July 31, 2014
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypesPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Molecular Cancer Research : MCR|June 28, 2015
Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer CellsPing Fan, Heather E Cunliffe, Philipp Y Maximov, et al.
The Journal of Biological Chemistry|December 1, 2004
Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrestMeiling Lu, Toni Kwan, Chunjiang Yu, et al.
Cancer Research|February 21, 2006
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alphaMaen Abdelrahim, Eric Ariazi, Kyounghyun Kim, et al.
Molecular Pharmacology|August 14, 2020
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Pageof 22

Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|December 8, 2005
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivationJoan S Lewis, Kathleen Meeke, Clodia Osipo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 4, 2004
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2Barry D Gehm, Anait S Levenson, Hong Liu, et al.
Gynecologic Oncology|June 20, 2012
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contaminationChristopher Korch, Monique A Spillman, Twila A Jackson, et al.
The Journal of Biological Chemistry|March 18, 2003
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functionsSandip K Mishra, Abhijit Mazumdar, Ratna K Vadlamudi, et al.
International Journal of Cancer|February 21, 2003
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alphaAnait S Levenson, Barry D Gehm, Sandra Timm Pearce, et al.
British Journal of Pharmacology|July 31, 2014
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypesPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Molecular Cancer Research : MCR|June 28, 2015
Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer CellsPing Fan, Heather E Cunliffe, Philipp Y Maximov, et al.
The Journal of Biological Chemistry|December 1, 2004
Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrestMeiling Lu, Toni Kwan, Chunjiang Yu, et al.
Cancer Research|February 21, 2006
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alphaMaen Abdelrahim, Eric Ariazi, Kyounghyun Kim, et al.
Molecular Pharmacology|August 14, 2020
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Pageof 22